153 related articles for article (PubMed ID: 20502009)
21. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
22. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
23. Targeting sphingosine kinase 1 in carcinoma cells decreases proliferation and survival by compromising PKC activity and cytokinesis.
Kotelevets N; Fabbro D; Huwiler A; Zangemeister-Wittke U
PLoS One; 2012; 7(6):e39209. PubMed ID: 22761740
[TBL] [Abstract][Full Text] [Related]
24. Attenuation of shock-induced acute lung injury by sphingosine kinase inhibition.
Lee C; Xu DZ; Feketeova E; Kannan KB; Yun JK; Deitch EA; Fekete Z; Livingston DH; Hauser CJ
J Trauma; 2004 Nov; 57(5):955-60. PubMed ID: 15580017
[TBL] [Abstract][Full Text] [Related]
25. Discovery and evaluation of inhibitors of human sphingosine kinase.
French KJ; Schrecengost RS; Lee BD; Zhuang Y; Smith SN; Eberly JL; Yun JK; Smith CD
Cancer Res; 2003 Sep; 63(18):5962-9. PubMed ID: 14522923
[TBL] [Abstract][Full Text] [Related]
26. HSP-70 mitigates LPS/SKI-induced cell damage by increasing sphingosine kinase 1 (SK1).
Ding XZ; Feng XR; Borschel RH; Nikolich MP; Feng J; Li YS; Hoover DL
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):1-7. PubMed ID: 20123033
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine kinase-1 inhibition protects primary rat hepatocytes against bile salt-induced apoptosis.
Karimian G; Buist-Homan M; Schmidt M; Tietge UJ; de Boer JF; Klappe K; Kok JW; Combettes L; Tordjmann T; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):1922-9. PubMed ID: 23816565
[TBL] [Abstract][Full Text] [Related]
28. A sphingosine kinase-1 inhibitor, SKI-II, induces growth inhibition and apoptosis in human gastric cancer cells.
Li PH; Wu JX; Zheng JN; Pei DS
Asian Pac J Cancer Prev; 2014; 15(23):10381-5. PubMed ID: 25556479
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells.
Duan HF; Wu CT; Lu Y; Wang H; Liu HJ; Zhang QW; Jia XX; Lu ZZ; Wang LS
Exp Cell Res; 2004 Aug; 298(2):593-601. PubMed ID: 15265705
[TBL] [Abstract][Full Text] [Related]
30. Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea.
Tani K; Tabuchi K; Hara A
Neurotox Res; 2016 Jan; 29(1):35-46. PubMed ID: 26472207
[TBL] [Abstract][Full Text] [Related]
31. Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.
Hengst JA; Hegde S; Paulson RF; Yun JK
Bioorg Med Chem Lett; 2020 Oct; 30(20):127453. PubMed ID: 32736077
[TBL] [Abstract][Full Text] [Related]
32. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases.
Gao P; Peterson YK; Smith RA; Smith CD
PLoS One; 2012; 7(9):e44543. PubMed ID: 22970244
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics.
Evangelisti C; Evangelisti C; Teti G; Chiarini F; Falconi M; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Beak DJ; Bittman R; Pyne S; Pyne NJ; Martelli AM
Oncotarget; 2014 Sep; 5(17):7886-901. PubMed ID: 25226616
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells.
Jung ID; Lee JS; Kim YJ; Jeong YI; Lee CM; Baumruker T; Billlich A; Banno Y; Lee MG; Ahn SC; Park WS; Han J; Park YM
Int Immunol; 2007 Apr; 19(4):411-26. PubMed ID: 17307797
[TBL] [Abstract][Full Text] [Related]
35. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration.
Döll F; Pfeilschifter J; Huwiler A
Endocr Relat Cancer; 2007 Jun; 14(2):325-35. PubMed ID: 17639048
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.
Schwalm S; Pfeilschifter J; Huwiler A
Br J Pharmacol; 2010 Aug; 160(7):1641-51. PubMed ID: 20649568
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor induces the loss of sphingosine kinase-1 by a cathepsin B-dependent mechanism.
Taha TA; Kitatani K; Bielawski J; Cho W; Hannun YA; Obeid LM
J Biol Chem; 2005 Apr; 280(17):17196-202. PubMed ID: 15710602
[TBL] [Abstract][Full Text] [Related]
38. Loss of sphingosine kinase-1 in carcinoma cells increases formation of reactive oxygen species and sensitivity to doxorubicin-induced DNA damage.
Huwiler A; Kotelevets N; Xin C; Pastukhov O; Pfeilschifter J; Zangemeister-Wittke U
Br J Pharmacol; 2011 Jan; 162(2):532-43. PubMed ID: 20883472
[TBL] [Abstract][Full Text] [Related]
39. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors.
Alshaker H; Srivats S; Monteil D; Wang Q; Low CMR; Pchejetski D
Breast Cancer Res Treat; 2018 Nov; 172(1):33-43. PubMed ID: 30043096
[TBL] [Abstract][Full Text] [Related]
40. A selective ATP-competitive sphingosine kinase inhibitor demonstrates anti-cancer properties.
Pitman MR; Powell JA; Coolen C; Moretti PA; Zebol JR; Pham DH; Finnie JW; Don AS; Ebert LM; Bonder CS; Gliddon BL; Pitson SM
Oncotarget; 2015 Mar; 6(9):7065-83. PubMed ID: 25788259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
